Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22785518)

  • 1. Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.
    Balink H; Apperloo MJ; Collins J
    Clin Nucl Med; 2012 Aug; 37(8):804-6. PubMed ID: 22785518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas.
    Yokoyama T; Takehara K; Yamamoto Y; Okame S; Shiroyama Y; Yokoyama T; Nogawa T; Sugawara Y
    Int J Clin Oncol; 2015 Oct; 20(5):960-6. PubMed ID: 25681878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.
    Na CJ; Jeong YJ; Lim ST; Sohn MH; Jeong HJ
    Clin Nucl Med; 2016 Feb; 41(2):e104-6. PubMed ID: 26545025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
    Ouyang L; Shi ZY; Lin ZG
    Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/CT as a molecular biomarker in ovarian cancer.
    Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
    Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoma of the ovary: additional role of 18F-FDG PET/CT.
    Santhosh S; Mittal BR; Raveendran A; Jain V; Nijhawan R; Kumar R; Bhattacharya A; Sharma SC
    Clin Nucl Med; 2013 May; 38(5):e230-2. PubMed ID: 23377413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additional value of attenuation correction CT acquired during 18F-FDG PET/CT in differentiating mature from immature teratomas.
    Cho A; Kim SW; Choi J; Kang W; Lee JD; Yun M
    Clin Nucl Med; 2014 Mar; 39(3):e193-6. PubMed ID: 23989446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT in serous psammocarcinoma of the ovary.
    Dong A; Wang Y; Zuo C
    Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of 18F-FDG PET/CT in ovarian immature teratomas when pathological examination results contradict clinical observations: a case report.
    Wang M; Jiang S; Zhang Y; Jiang C; Xia F; Lyu W; Ma X
    Medicine (Baltimore); 2017 Dec; 96(50):e9171. PubMed ID: 29390326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
    Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
    Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT findings of mature cystic teratoma with malignant transformation: comparison with mature cystic teratoma.
    Park SB; Cho KS; Kim JK
    Clin Imaging; 2011; 35(4):294-300. PubMed ID: 21724123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge?
    Mapelli P; Mangili G; Picchio M; Rabaiotti E; Gianolli L; Messa C; Candiani M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):314-7. PubMed ID: 23270913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer.
    Zytoon AA; Murakami K; Eid H; El-Gammal M
    Acta Radiol; 2013 Apr; 54(3):340-8. PubMed ID: 23319725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
    De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal and Nodal Gliomatosis Mimicking Metastasis on FDG PET/CT in a Patient With Ovarian Immature Teratoma.
    Lee SM; Choi MC; Lee JW; Kim T; Jang SJ
    Clin Nucl Med; 2023 Aug; 48(8):707-709. PubMed ID: 37220221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT of a benign ovarian Brenner tumor.
    Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
    Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-Fluorodeoxyglucose Uptake in Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Associated With an Immature Teratoma.
    Nakamoto R; Nakamoto Y; Ishimori T; Fushimi Y; Togashi K
    Clin Nucl Med; 2017 Feb; 42(2):157-160. PubMed ID: 27922872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative 18F-2-fluorodeoxyglucose PET/CT predicts good cancer specific survival in patients with a suspicion of recurrent ovarian cancer.
    Hebel CB; Behrendt FF; Heinzel A; Krohn T; Mottaghy FM; Bauerschlag DO; Verburg FA
    Eur J Radiol; 2014 Mar; 83(3):463-7. PubMed ID: 24368010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT imaging features of Rosai Dorfman disease: a rare cause of massive generalized lymphadenopathy.
    Karunanithi S; Singh H; Sharma P; Naswa N; Kumar R
    Clin Nucl Med; 2014 Mar; 39(3):268-9. PubMed ID: 24217542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.